3.73
+0.44(+13.37%)
Currency In USD
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States of America
Phone
360 949 1041
Website
Sector
Healthcare
Industry
Biotechnology
Employees
156
First IPO Date
July 22, 2021
| Name | Title | Pay | Year Born |
| Mr. Sean McClain | Founder, Chief Executive Officer, President & Director | 1.07M | 1990 |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & Chief Financial Officer | 813,300 | 1973 |
| Dr. Andreas Busch Ph.D. | Chief Innovation Officer & Member of Scientific Advisory Board | 1.17M | 1963 |
| Mr. Wen Sha | Chief of Staff | 0 | N/A |
| Ms. Shelby Walker J.D. | Chief Legal Officer | 0 | 1975 |
| Melissa Patterson Ph.D. | Chief of Staff | 0 | N/A |
| Mr. Todd Bedrick CPA | Senior Vice President & Chief Accounting Officer | 0 | N/A |
| Mr. Alexander Khan CPA | Vice President of Finance & Head of Investor Relations | 0 | N/A |
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy | 0 | N/A |
| Ms. Karin Wierinck | Chief People Officer | 0 | N/A |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.